About
Technology
Issues
FAQ
Links
Official Page
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.